All EQA samples undergo rigorous validation for stability, homogeneity, and biosafety to ensure their applicability and scientific validity in real-world testing scenarios. The interpretation of results is conducted by experienced technical teams based on WHO consensus standards and is further cross-reviewed by senior andrology laboratory experts, guaranteeing the objectivity, consistency, and technical authority of the assessment conclusions.

Each participant will receive a structured, personalized performance evaluation report. This report not only identifies the sources of deviation but also provides targeted recommendations for improvement, empowering laboratories to precisely optimize their Standard Operating Procedures (SOPs) and strengthen their internal quality control systems.

Recognizing that equitable access to reliable semen analysis requires quality solutions adaptable to diverse resource settings, we warmly welcome technical collaborations with international partners. Drawing on our extensive experience in implementing large-scale EQA programs across China's varied healthcare landscapes, we propose exploring joint initiatives in the following areas:

International exchange of EQA (non-biological) samples to assess the comparability of semen parameter reporting across different regions;

Harmonization of assessment protocols and interpretation criteria to ensure alignment with the WHO 6th Edition Laboratory Manual;

Development of tiered EQA models tailored to laboratories operating at varying resource levels.

Through this collaboration, we are united in a shared mission: to ensure that every semen analysis performed, anywhere in the world, serves as a trustworthy, comparable, and scientifically robust foundation for both clinical practice and research.